webinar register page

Webinar banner
Unlock Your Healthcare AI Startups' Potential with NVIDIA
Healthcare has been on the verge of transformation for years, if not decades. But in a matter of months, the pandemic broke down long standing barriers and accelerated digital health at a pace few could have imagined. Last year, CB insights shared that 6.6 billion dollars funding (record high) went into investing in healthcare AI startups globally. Stanford AI Index shared the drug and medical industries took in the biggest share of overall AI private investment in 2020, absorbing more than $13.8 billion — 4.5 times greater than in 2019 and nearly three times more than the next category of autonomous vehicles. To cultivate such innovation and transformation in the industry, NVIDIA Inception, an acceleration platform for AI, data science and HPC startups, provides go-to-market support, expertise, and technology. There are more than 9000 startups cross industries in NVIDIA Inception, with healthcare being the largest industry of 1400+ members globally. We see innovation across medical imaging, medical instruments, drug discovery, digital health, and genomics. In this talk, you will hear about all of the free resources provided in Inception for startups and two leading startups' journey in the program.

Jan 25, 2022 09:00 AM in Pacific Time (US and Canada)

* Required information


Renee Yao
Global Healthcare AI Startups Lead @nVIDIA
Renee Yao (she/her) leads global healthcare AI startups at NVIDIA, managing more than 1,400 healthcare startups in the digital health, medical instrument, medical imaging, genomics, and drug discovery segments. Previous to this role, she was a senior product manager and product marketing manager for AI systems, building bundle solutions and reference architectures for the self-driving car, telecom, and big data analytics industries. Yao graduated from the Haas School of Business at UC Berkeley with a focus in economics and IT. She was named one of the top 50 B2B product marketers to watch. In her free time, she enjoys competitive ballroom dancing, reading, and traveling.
Christopher Bouton, PhD
CEO @Vyasa Analytics
Chris is the CEO of Vyasa Analytics, applying novel deep learning approaches for enterprise clients. Previously, Chris was the CEO of Entagen a software company founded in 2008 that provided innovative Big Data products including Extera and TripleMap. Entagen’s technologies won numerous awards including the “Innovative Technology of the Year Award for Big Data” from the Massachusetts Technology Leadership Council in 2012 and Entagen was recognized as a Gartner “Cool Vendor” in the Life Sciences in 2013. Entagen was acquired by Thomson Reuters in 2013. Prior to his role as the CEO of Entagen, he worked as a computational biologist at LION Bioscience Research Inc. and Aveo Pharmaceuticals from 2001 and 2004, leading the microarray data analysis functions at both companies. Chris is an author on over a dozen scientific papers and book chapters and his work has been covered in a number of industry news articles. He received his Ph.D. in Neuroscience from Johns Hopkins University.
Andrew Gostine, MD, MBA
CEO and co-founder @Artisight
Andrew Gostine is a practicing physician and CEO of Artisight, Inc., an AI-enabled, IOT sensor platform for healthcare automation and optimization. Artisight is a member of the NVIDIA Inception Program.